1Assistant Professor, Department of Pharmacology, Anjuman-I-Islam’s Kalsekar Technical Campus – SOP, New Panvel, Navi Mumbai, Maharashtra, India.
2Student of Anjuman-I-Islam’s Kalsekar Technical Campus – SOP, New Panvel, Navi Mumbai, Maharashtra, India
Diabetic neuropathy is a chronic complication of diabetes that leads to nerve damage and persistent pain. Conventional pharmacological treatments provide symptomatic relief but often lead to side effects and limited long-term efficacy. This study focused on formulating and evaluating a polyherbal oil as a natural alternative for managing diabetic neuropathy pain. The formulation incorporated bioactive ingredients such as sea buckthorn oil, Ashwagandha, mahanarayan oil, curcumin, camphor, and peppermint oil, known for their antioxidant, anti Inflammatory, and neuroprotective properties. The study involved conducting preliminary phytochemical screening to identify key active constituents responsible for the antioxidant and anti-inflammatory effects. Formulations were developed with varying compositions and subjected to physicochemical evaluation, including viscosity, spreadability, pH, and stability analysis. Analytical assessments such as total phenolic content (TPC) measurement was conducted to determine antioxidant activity. The results demonstrated that the polyherbal oil possesses promising antioxidant properties, supporting its potential as a safe and effective alternative to synthetic treatments for diabetic neuropathy. However, further in vivo studies and clinical trials are required to confirm its mechanism of action, long-term stability, and therapeutic efficacy.
Diabetes mellitus is a heterogeneous chronic metabolic disorder characterized by high blood glucose levels due to abnormalities in insulin secretion and/or action. Carbohydrate, fat, and protein metabolism dysfunctions due to hyperglycaemia are systemic and impair the functions of many organs in the body. These perturbations are progressive and result primarily from the deleterious effects of hyperglycaemia and its associated metabolic derangements on the normal architecture and physiology of these complications comprise organ damage, dysfunction, and finally organ failure and involve some body organs, especially eyes, kidneys, heart, and nerves. It manifests as retinopathy with progression to blindness. Nephropathy and possible renal failure; Complications associated with the kidney. These include coronary heart disease and hypertension. Complications related to the nerves are manifestations like neuropathies which can be peripheral and/or autonomic. Diabetes, the rapidly growing global epidemic, has become one of the most urgent and significant health problems facing the human society currently urbanization and the shift towards modern lifestyle habits have been widespread with high rates of economic development which paralleled the rising prevalence of diabetes around the world. [1]
1.1 Emerging risks of Diabetes mellitus
Complications classically ascribed to diabetes mellitus include macrovascular disorders such as coronary heart disease, stroke and peripheral arterial disease, and microvascular disorders that entail diabetic kidney disease, retinopathy and peripheral neuropathy. Moreover, heart failure is the most common first manifestation of cardiovascular disease in individuals with type 2 diabetes mellitus. In some countries or regions, cancer is the leading cause of death in individuals with diabetes mellitus. Diabetes mellitus presents with traditional complications such as stroke, Coronary heart disease and heart failure, peripheral neuropathy, retinopathy, diabetic kidney disease and peripheral vascular disease Despite advances in the management of diabetes mellitus, Associations between diabetes mellitus and cancer, infections, functional and cognitive disability, Liver disease and affective disorders are instead becoming prevalent.
1.2 Diabetic Neuropathy
Diabetic neuropathy is a common and serious complication of diabetes mellitus, affecting up to 50% of patients with type 1 or type 2 diabetes. It is a neurodegenerative disorder that primarily impacts the peripheral nervous system, often starting in the distal sensory neurons and progressing proximally. Key risk factors include poor glycaemic control, longer diabetes duration, older age, obesity, hypertension, dyslipidemia, and smoking. The two main types are distal symmetric polyneuropathy and autonomic neuropathy. Early detection and intervention are critical, as diabetic neuropathy significantly contributes to morbidity, mortality, and non-traumatic amputations. Effective management relies on optimized blood sugar control, multifactorial interventions, and symptomatic treatment. [2]
1.3 Types of Diabetic neuropathy
• Peripheral neuropathy: This type of neuropathy in most clinical practice is seen as sensory-neuronal neuropathy in patients with diabetes. It is defined by slowly progressive symmetric numbness in the distal foot, paraesthesia, with or without neuropathic pain, and absent Achilles tendon reflexes. It may or may not be related to weakness. This neuropathy comprises the main underlying cause of hospital admissions for foot ulcers, infection, and gangrene.
• Proximal Neuropathy: Proximal neuropathy is a diabetes-related nerve disorder causing pain and weakness in the hips, thighs, or legs. A subtype, diabetic amyotrophy, presents with sudden, one-sided pain and muscle weakness.
• Autonomic Neuropathy: Poor glycaemic control in diabetes can damage autonomic nerves, causing issues like irregular heart rate, digestive problems, erectile dysfunction, dry skin, and sweating disorders. This may lead to ulcers, gangrene, and potential limb amputation.
• Focal Neuropathy: Focal neuropathy in diabetes is a sudden, painful nerve injury due to reduced blood flow, often affecting cranial and peripheral nerves. It usually resolves in about six weeks and includes conditions like Bell’s palsy and carpal tunnel syndrome. [3]
1.4 Pathophysiology of Diabetic Neuropathy
The exact mechanism of diabetic neuropathy is not known but it is taken up that toxic effect of hyperglycaemia is considered as the cause of development of diabetic neuropathy. Other factors include:
• Enhanced Polyol Pathway Activity:
Hyperglycaemia from reduced insulin increases polyol pathway activity, where aldose reductase converts glucose to sorbitol, consuming NADPH. Sorbitol then converts to fructose, raising NADH levels. Excess sorbitol causes intracellular osmotic stress, contributing to diabetic complications.
• Oxidative Stress:
Oxidative stress is initiated by the formation of harmful free radicals due to glucose metabolism and deficient of antioxidant defence which plays a major role in the pathogenesis of diabetic neuropathy.
• Microvascular Changes:
Diabetic neuropathy is caused by reduced blood flow to nerves due to damaged small blood vessels, leading to poor oxygen supply, swelling, and pressure buildup. High blood sugar worsens this by further limiting oxygen to sensory nerves. Despite increased leg blood flow in some cases, oxygen deficiency remains a key factor, possibly linked to sympathetic nerve dysfunction.
• Damaged Nerves:
Damaged nerve endings in diabetic neuropathy may generate abnormal signals interpreted as pain by the CNS. Nerve injury also alters ion channel expression, increasing nerve excitability and contributing to neuropathic pain. [4]
1.5 WHO Data on Diabetic Neuropathy
According to the World Health Organization (WHO), the global number of individuals with diabetic neuropathy has more than tripled since 1990, reaching 206 million cases in 2021. It is estimated that 50% to 66% of people with diabetes will eventually develop diabetic peripheral neuropathy (DPN) during their lifetime.
The prevalence of DPN increases with both age and the duration of diabetes. Studies indicate that after 5 years of living with diabetes, approximately 26% of patients develop peripheral neuropathy. This figure rises to 41% after 10 years of the condition.
Mortality rate of Diabetes:
According to the World Health Organization (WHO), diabetes mellitus was responsible for approximately 26.9 deaths per 100,000 population in India in 2021. This means that diabetes was the direct cause of around 1.6 million deaths that year. The diabetes mortality rate increased 3% by age from 2000 to 2019.
Impact of Diabetic Neuropathy on Mortality:
A study revealed that adults with diabetes who also have peripheral neuropathy and a foot ulcer face more than twice the risk of mortality compared to those without these complications. [5]
Diabetic neuropathy is a chronic and progressive complication of diabetes that significantly impairs the quality of life due to persistent nerve pain, inflammation, and oxidative stress. Existing pharmaceutical treatments often provide limited relief and are associated with side effects such as sedation, gastrointestinal issues, or dependency. There is a growing demand for safer, natural alternatives that offer effective symptom management with minimal side effects. Despite the therapeutic potential of medicinal plants like Sea Buckthorn, Ashwagandha, and Curcumin, their synergistic use in a topical polyherbal oil formulation for diabetic neuropathy remains underexplored. This project aims to develop and evaluate a stable, effective, and skin-compatible herbal oil enriched with Sea Buckthorn and other neuroprotective botanicals to provide a holistic, side-effect-free approach to managing diabetic neuropathy pain.
2. PRE-FORMULATION STUDIES
2.1 Phytochemical Profile:
SEA BUCKTHORN SEED OIL
Appearance: Clear, viscous, oily
Colour: Golden yellow to Amber
Odour: Characteristic nutty to mildly pungent
pH: 2.5 (acidic)
Viscosity: 40-50 mPa’s at 25°C
Refractive index: 1.465-1.475
Solubility: Soluble in fixed oils and alcohol
Phytochemical Constituents
• Fatty acids: Linoleic acid (omega 6), Alpha linoleic acid (omega 3), oleic acid (omega 9), Palmitoleic acid (omega 7), Saturated fatty acids
• Flavonoids: Isorhamnetin, kaempferol, Quercetin, Proanthocyanidine, Catechin
• Vitamins: Vitamin C, Vitamin E (Tocopherols and Tocotrienols), Vitamin A (Carotenoids like beta-carotene), Vitamin K, B-complex vitamins – B1, B2, B6, folic acid
• Phenolic Compounds: Gallic acid, Caffeic acid, Ferulic acid, Ellagic acid
• Phytosterols: Beta-sitosterol, Campesterol, Stigmasterol
• Triterpenoid, Saponins, Tannins, Alkaloids, Amino acids and minerals. [6]
Therapeutic benefits
Sea buckthorn seed oil, rich in omega-3, omega-6, vitamin E, and phytosterols, offers anti-inflammatory, antioxidant, and neuroprotective benefits. It helps relieve diabetic neuropathy symptoms by reducing nerve inflammation, aiding regeneration, and improving circulation. Additionally, it promotes wound healing, skin repair, heart and liver health, immunity, and acts as a natural moisturizer. [7]
ASHWAGANDHA OIL
Appearance: Clear to slightly turbid viscous fluid
Colour: Light brown to reddish brown
Odour: Characteristic earthy, slightly pungent herbal smell
Texture: Oily, Smooth, and Non-sticky after application
pH: 5.5-6.5
Viscosity: 130-159cP (Depends on temperature)
Refractive index: 1.47 – 1.48
Solubility: Insoluble in water, miscible with oils & ethanols
Phytochemical Constituents: Withanolides, Alkaloids, Saponins, Flavonoids, Steroidal lactones, Tannins, Fatty acids, Fatty acids, Vitamin E (Tocopherols). [8]
Therapeutic Benefits:
MAHANARAYAN OIL
Appearance: viscous, clear to slightly turbid oily liquid
Colour: Reddish brown to dark brown
Odour: Strong herbal, slightly pungent and spicy aroma
Texture: Smooth and oily, leaves a greasy layer when applied
pH: 5.5-6.5 (in emulsion form)
Viscosity: 120-150cP at 25°C
Refractive index: 1.470-1.480
Solubility: Insoluble in water, miscible with oils and ethanol
Phytochemical Constituents: Alkaloids (Piperine, Berberine), Flavonoids (Quercetin, Kaempferol), Tannins (Polyphenolic compounds), Glycosides (Iridoid and Cardiac Glycosides), Terpenoids & Volatile oils (Cineole, Camphene, Menthol), Saponins (Withanosides, Shatavarin), Steroids (Plant Steroids- Beta-sitosterol). [10]
Therapeutic Benefits:
CURCUMIN EXTRACT
Appearance: Fine crystalline or amorphous powder (dried extract)
Colour: Bright yellow to orange
Odour: Mild, Characteristic earthy or spicy odour
Texture: Smooth, Fine powder
pH (suspension): Slightly acidic (around 6.5)
Partition coefficient: Log P ~ 3.3 (Lipophilic)
Melting point: ~183°C
Solubility: Practically insoluble in water, Soluble in ethanol & Oils.
Stability: Sensitive to light, heat, and alkaline pH
Appearance in Base: Disperses well in oils with mild heating
Phytochemical Constituents: Curcumin (Principle active compound), Demethocycurcumin, Bisdemethoxycurcumin, zingiberene (mild extract form).[12]
Therapeutic Benefits:
CAMPHOR
Appearance: Crystalline, waxy solid
Colour: White or colourless
Odour: Strong, penetrating, aromatic
Texture: Brittle, Dry crystals
Partition coefficient: Log P ~2.4 (Lipophilic)
Melting point: ~175-177°C
Boiling point: ~204°C
Solubility: Soluble in ethanol, oils and chloroform, Insoluble in water
Volatility: High (volatile at room temperature)
Stability: Light and heat sensitive
Phytochemical Constituents: Terpenoid (Monoterpene ketone), Monoterpenoids. [14]
Therapeutic Benefits:
PEPPERMINT OIL
Appearance: Clear, mobile liquid
Colour: Colourless to pale yellow
Odour: Strong, fresh, sharp, Menthol like aroma
Texture: Watery, less viscous
pH: 3.0-6.0
Refractive index: 1.460-1.467
Solubility: Soluble in alcohol, oils, and chloroform, Insoluble in water
Stability: Light sensitive, should be stored in airtight amber bottle
Phytochemical Constituents: Terpenoids (Menthol, Menthone), Esters (Menthyl acetate), Flavonoids, Oxides (cineole-eucalyptol). [16]
Therapeutic Benefits:
3. AIM & OBJECTIVES
3.1 AIM:
To develop and evaluate a Sea Buckthorn-Enriched Polyherbal Oil as a natural, safe, and effective alternative for managing diabetic neuropathy pain, focusing on its antioxidant properties while minimizing side effects.
3.2 OBJECTIVE:
• To develop a stable polyherbal oil formulation for alleviating diabetic neuropathy pain.
• To understand the mechanism of action and safety profile of the formulation compared to existing treatments.
• To develop a cheaper formulation for alleviating diabetic neuropathy pain.
• To contribute to the development of a natural, alternative remedy for managing diabetic neuropathy pain, offering a safer option than conventional treatments.
4. EXPERIMENTAL WORK
4.1 Materials and Methods
Material Used in the Formulation
Table 1. Ingredients Used and Their Brand Name
SR.NO |
INGREDIENTS |
CATEGORY |
F1 (15 ml) |
F2 (15 ml) |
1 |
Sea buckthorn seed oil |
API, Antioxidant, Neuroprotective |
8.5 ml |
9.5ml |
2 |
Ashwagandha oil |
Anti-inflammatory |
2 ml |
1.4 ml |
3 |
Mahanarayan oil |
Analgesic |
1.2 ml |
1 ml |
4 |
Camphor |
Analgesic, Soothing effect |
1 g |
1 g |
5 |
Curcumin extract |
Antioxidant, Anti-inflammatory |
0.1 g |
0.1 g |
6 |
Peppermint oil |
Fragrance, Cooling effect, Analgesic |
2.2 ml |
2 ml |
FORMULATION OF POLYHERBAL OIL
Table 2. Formulation Table
SR. NO. |
INGREDIENTS |
BRAND NAME |
1 |
Sea buckthorn seed oil |
RV Essentials |
2 |
Ashwagandha oil |
AVI Naturals |
3 |
Mahanarayan oil |
Baidyanath |
4 |
Camphor |
OM shanti |
5 |
Curcumin extract |
Saptamveda |
6 |
Peppermint oil |
Cesaro |
PREPARATION METHOD:
5. EVALUATION OF POLYHERBAL OIL
Characterization of Formulated Oil
The characterization study includes a methodical technique used to assess and comprehend the key features for a pharmaceutical and herbal composition. It entails examining the biological, chemical, and physical characteristics in order to guarantee that the formulation is high quality, stable, beneficial, and safe to use. This study is an important aspect of product development since it provides scientific data to justify the formulation's intended use.
5.1 PHYTOCHEMICAL TESTS
Phytochemical investigation or phytochemical tests is the qualitative and/or quantitative examination of formulations for the presence of bioactive components that includes alkaloids, flavonoids, tannins, saponins, glycosides, terpenoids and or phenolic compounds. These tests aid in determining the potential for treatment and medicinal properties in the polyherbal oil formulations.
1. DETECTION OF ALKALOIDS
Mayer’s Test:
1 mL of the extract is combined with 1 mL of Mayer’s reagent. The presence of alkaloid is confirmed by appearance of white or yellowish precipitate.
Wagner’s Test:
To 1 mL of extract, few drops of wagners’s reagent is added. The confirmation of Reddish-brown precipitate indicates the presence of alkaloids.
2. DETECTION OF FLAVONOIDS
Shinoda Test:
Small piece of magnesium ribbon is added to 2 mL of the extract. Carefully add 2–3 drops of concentrated HCl. The red color change is due to the presence of flavonoids.
Alkaline Test:
To 2 mL of the extract, few drops of 10% NaOH solution is added. Then, a few drops of dilute HCl is added to the solution. Intense yellow color appears on addition of NaOH and disappears after adding HCl leaving a light yellow colour indicating the presence of flavonoids.
3. DETECTION OF PHENOL
Ferric Chloride Test:
To 1 mL of the extract of oil formulation, few drops of 5% ferric chloride solution is added. A different blue, green, purple, or black coloration signifies the presence of phenolic constituents.
4. DETECTION OF TANNINS
Lead Acetate Test:
To 1 mL of the extract of oil formulation, added a few drops of 10% lead acetate solution. The presence of tannins is confirmed by white or yellow precipitate.
5. DETECTION OF CARBOHYDRATES
Molisch’s Test:
To 1 mL of the extract of oil formulation, 2-3 drops of Molisch’s reagent is added, followed by 1 mL of concentrated H?SO? along the sides of the test tube without stirring. Formation of a violet or purple ring at the junction indicates the presence of carbohydrates.
Benedict’s Test:
1 mL of the extract is combined with 1 mL of Benedict’s reagent. Boil the mixture for 2–5 minutes in a water bath. Confirmation of orange/red, or brick-red precipitate describes the presence of reducing sugars.
1. DETECTION OF STEROIDS AND TRITERPENOIDS
Salkowski Test:
1 mL of the extract is dissolved in 1 mL of chloroform. Carefully add 2 mL of concentrated H?SO? along the side of the test tube to form a layer. Presence of a reddish-brown ring at the interface shows the presence of steroids and triterpenoids.
2. DETECTION OF CURCUMIN
Boric Acid Test:
Small quantity of boric acid is mixed into a few milliliters of ethanol containing the extract. Formation of a reddish or orange-red complex indicates the presence of curcumin, due to complex formation between curcumin and boric acid.
3. DETECTION OF CAMPHOR
2, 4-Dinitrophenylhydrazine (DNPH) Test:
A few drops of 2,4-DNPH reagent is added to the oil extract. The appearance of a yellow, orange, or red precipitate indicates the presence of a carbonyl functional group, suggesting compounds such as camphor or acetone.
4. DETECTION OF PEPPERMINT OIL
Test for menthol – Nitric Acid Test:
To the extract 1 mL of concentrated nitric acid is added, followed by gentle heating. Formation of yellow to orange coloration or yellow nitration product indicates the presence of menthol. [18]
5.2 EVALUATION TESTS
The prepared oil Formulation was subjected to various evaluation tests such as physical characterization which includes colour, odour & appearance. Additionally, various physico-chemical parameters such as pH, viscosity, spreadability and other parameters were analysed to ensure the formulation's stability, compatibility, and effectiveness for topical application.
• Colour: The oil Formulation in a glass beaker was placed against a white background under natural day light and colour was observed.
• Odour: Take a few drops of oil in a clean porcelain dish or on blotting paper. Bring it close to the nose (without inhaling deeply). The type, intensity, and pleasantness of the smell was assessed (e.g., herbal, pungent, floral, mild).
• Texture: 2-3 drops of the oil was applied on the back of a clean hand. It was spread gently using the fingertip in circular motions; and the texture was noted (greasy, smooth, thick, thin, sticky, or silky).
• Clarity: The oil was poured into a clean, dry test tube and was hold against a light source or white background. Then it was observed for clarity, cloudiness, suspended matter, or sediments.
• Homogeneity: The oil bottle was shaken gently and visually inspected for any phase separation, sedimentation, or layering.
• After Feel: The oil was applied in small amount on the skin (hand or forearm). It was rubbed gently and allowed to absorb. After 5–10 minutes, any sensation: greasy, dry, smooth, sticky, hydrated, cooling or any irritation was noted.
1. Determination of pH
The pH meter was calibrated using standard buffer solution (pH 7.0). The electrode was washed with distilled water and then gently dried with a tissue paper. The pH electrode was then dipped in the oil formulation and a stable reading was recorded.
2. Determination of Viscosity
The viscosity of the oil formulation was determined using a Brookfield Viscometer. The oil was placed in a clean beaker and maintained at 25 ± 1°C. A suitable spindle (Spindle No. 3) was selected and immersed into the oil without touching the sides or bottom. The viscometer was operated at 10 rpm, and the viscosity reading was recorded in centipoise (cP) after stabilization.
3. Determination of Specific Gravity
A pycnometer (specific gravity bottle) is used to measure the specific gravity of the oil-based formulation. The empty, clean, and dry bottle was first weighed and its weight noted (W1). It was subsequently filled with the oil formulation and reweighed (W2). After cleaning and drying, the bottle was filled with distilled water and weighed (W3). The specific gravity was calculated using the formula for specific gravity and the result was expressed as a unitless ratio compared to water.
SG = Weight of the oil (g) / Weight of an equal volume of water (g)
4. Determination of Spreadability
The spreadability of the oil formulation was evaluated using two glass slides and a standard weight method. One ml of the oil was placed between two clean glass slides, which were then pressed uniformly by placing a 50g weight on top for 5 minutes. After removing the weight, the diameter of the spread oil film was measured using a ruler. The spreadability (S) of the formulation was calculated using the formula:
S = M (g) × L (cm) / T (sec)
5. Determination of Washability
To assess washability, about 1 mL of the oil formulation was applied to a small section of the skin. The oil was gently rubbed and left undisturbed for 5 minutes. The area was then rinsed under running tap water for 30 seconds without using soap or detergent. The extent to which the oil was removed was visually assessed and categorized as easily washable, moderately washable, or poorly washable.
6. Determination of Irritancy/Sensitivity
The irritancy potential of the oil formulation was evaluated by applying a small amount (approximately 0.5 mL) of the oil to a marked area (1 cm²) on the forearm of healthy human volunteer. The site was observed for any signs of redness, itching, swelling, or rashes at regular intervals—specifically at 30 minutes, 1 hour, and 24 hours after application. Volunteers were instructed not to wash the area during the observation period. No adverse reactions indicated that the formulation was non-irritant and safe for topical use. [19]
5.3 STABILITY STUDIES
Stability studies are conducted to determine how well a pharmaceutical or cosmetic product maintains its physical, chemical, microbiological, and functional properties over time under the influence of various environmental factors such as temperature, humidity, and light.
The oil formulation was stored in airtight glass containers at 37°C ± 2°C for a period of three months. Observations were recorded at three intervals—after 1 month, after 2 months, and after 3 months. At each interval, the formulation was evaluated for any changes in color, odor, pH, and viscosity. The results were compared with initial baseline values to assess the formulation’s physical and chemical stability under accelerated conditions.
The thermal stability of the oil formulation was evaluated at the same three intervals -after 1, 2, and 3 months. At each time point, approximately the stored oil was subjected to three cycles of heating at 45–60°C followed by cooling to room temperature. After each cycle, the sample was inspected for phase separation, precipitation, or any visible changes. The absence of such changes indicated thermal stability over time. [20]
Formulations for Stability Study
6. ANTIOXIDANT ACTIVITY
Antioxidant activity is the capacity of a compound to neutralize free radicals—unstable molecules that can damage cells, proteins, and DNA. This activity helps protect the body from oxidative stress, which is linked to aging and diseases like cancer, diabetes, and heart disorders. ntioxidants help neutralize free radicals by donating electrons, thereby protecting cells from potential damage.
6.1 DETERMINATION OF TOTAL PHENOLIC CONTENT
Determination of Total Phenolic Content (TPC) is a method to measure the amount of phenolic compounds in a sample, which are key natural antioxidants. It’s commonly done using the Folin–Ciocalteu reagent (FCR), which reacts with phenolics to produce a blue color. The color intensity, as determined using a spectrophotometer, indicates the concentration of phenolic compounds. Since phenolic compounds can neutralize free radicals, higher TPC indicates stronger antioxidant activity. [21]
PROCEDURE:
From the 100 µg/mL stock solution, pipette out the required volumes and dilute to 10 mL using distilled water.
Table 3. Preparation of Stock Solution
Final concentration (µg/ml) |
Volume of stock solution |
Final volume (ml) |
10 µg/ml |
1 ml |
10 ml |
25 µg/ml |
2.5 ml |
10 ml |
50 µg/ml |
5 ml |
10 ml |
75 µg/ml |
7.5 ml |
10 ml |
Instead of gallic acid or sample, take 1 mL of methanol and follow the same procedure. [22]
Standard, Sample and Blank Solution
7. EXPERIMENTAL RESULT
Two formulations of the polyherbal oil (F1 and F2) were successfully developed using varying concentrations of the active herbal ingredients. Both formulations were evaluated for their physical appearance, physicochemical properties, and stability.
Labelling of the Polyherbal Oil
7.1 Physical Characterization
The physical properties of the oil formulations were evaluated, and the findings are presented below:
Table 4
SR.NO. |
ORGANOLEPTIC PARAMETERS |
OBSERVATION |
1 |
Colour |
Golden – Yellow Colour |
2 |
Odour |
Characteristic Herbal Odour With Peppermint Scent |
3 |
Texture |
Smooth, Non-Greasy |
4 |
Clarity |
Clear, Slightly Translucent |
5 |
Homogeneity |
No Phase Separation |
6 |
After feel |
Moisturizing, Cooling Sensation |
7.2 Physico-Chemical Properties
The various physicochemical parameters of the oil formulations (F1 and F2) were evaluated to assess their physical and chemical properties. The results are mentioned below:
Table 5
SR.NO. |
PARAMETERS |
F1 |
F2 |
1 |
pH |
5.3 |
5.1 |
2 |
Viscosity (10 rpm) |
175 cP |
189 cP |
3 |
Specific gravity |
0.88 g/ml |
0.92 g/ml |
4 |
Spreadability |
8 g.cm/sec |
7.5 g.cm/sec |
5 |
Washability |
Easily washable |
Easily washable |
6 |
Irritancy/sensitivity |
No irritation observed |
No irritation observed |
The physicochemical properties of formulations F1 and F2 were found to be within the acceptable range for topical herbal oils.
Both formulations (F1 and F2) exhibited acceptable physicochemical characteristics. F1 showed slightly better spreadability and lower viscosity compared to F2, while both were easily washable and caused no skin irritation, indicating good topical compatibility.
7.3 Stability Study
The stability study of the oil formulation included Accelerated stability testing and thermal stability testing at 3 intervals in 3 months and different parameters were assessed. The results are mentioned below:
Table 6
SR.NO. |
PARAMETERS |
INITIAL |
AFTER 1 MONTH |
AFTER 2 MONTHS |
AFTER 3 MONTHS |
1 |
Physical appearance and odour |
Golden- yellow, Herbal odour |
Same as initial |
Same as initial |
Same as initial |
2 |
pH |
5.3 |
5.2 |
5.2 |
5.1 |
3 |
Viscosity |
175 cP |
178 cP |
179 cP |
181 cP |
4 |
Thermal stability
|
No phase separation or precipitation |
No phase separation or precipitation |
No phase separation or precipitation |
No phase separation or precipitation |
The stability study revealed that the formulation remained stable over 3 months with no significant changes in color, odor, pH, or viscosity. No phase separation or precipitation was observed, confirming the physical and thermal stability of the oil throughout the testing period.
7.4 Phytochemical Tests
The phytochemical examination of the polyherbal oil formulation confirmed the presence of alkaloids, flavonoids, phenols, tannins, steroids, terpenoids, and other chemical constituents. These bioactive compounds suggest that the formulation possesses significant antioxidant and anti-inflammatory activity, which are essential for the treatment of diabetic neuropathy pain. A summary of the results is provided in the following table.
Table 7. Identification Tests for Sea Buckthorn
TESTS |
OBSERVATION |
INFERENCE |
Mayer’s test
|
Yellowish white ppt
|
Presence of Alkaloids |
Wagner’s test
|
Reddish- brown
|
Present of Alkaloids |
Shinoda test
|
Red colour
|
Presence of Flavonoids |
Alkaline test |
Yellow colour
|
Presence of Flavonoids |
Ferric chloride test
|
Red-green colour
|
Presence of Phenol |
Lead acetate test
|
Yellow ppt
|
Presence of Tannins |
Molisch’s test
|
Purple-red ring
|
Presence of Carbohydrates |
Benedict’s test
|
Brick red ppt
|
Presence of Carbohydrates |
Table 8. Identification Tests for Other Phytochemicals
TESTS |
OBSERVATION |
INFERENCE |
Salkowski test
|
Reddish-brown color at the interface of the two layers
|
Presence of Steroids and Triterpenoids
|
Boric acid test
|
Reddish- brown
|
Presence of Curcumin |
2,4-Dinitrophenylhydrazine (DNPH) Test
|
Bright orange- red ppt |
Presence of Camphor |
Nitric acid test
|
Blue colour turns yellow
|
Presence of Menthol |
8. ANALYTICAL RESULT
8.1 Anti-Oxidant Activity (Total Phenolic Content)
The Total Phenolic Content (TPC) assay was conducted to evaluate the antioxidant potential of the formulated oil. This assay was performed using the Folin–Ciocalteu method, which is a widely accepted procedure for determining the phenolic content in plant-based formulations. The results obtained from the assay are detailed below and are expressed in terms of gallic acid equivalents (GAE), indicating the presence of phenolic compounds contributing to the formulation’s antioxidant activity.
Standard Gallic Acid Absorbance at Different Concentrations
Table 9
CONCENTRATION (µg/mL) |
ABSORBANCE |
10 |
0.0261 |
20 |
0.0537 |
50 |
0.0954 |
75 |
0.1248 |
Standard Calibration Curve was Plotted (Absorbance Vs Concentration)
Sample Absorbance Recorded Against Blank (Sample 1 and Sample 2)
Table 10
SAMPLES |
ABSORBANCE |
CONCENTRATION (µg /ml) |
Sample 1 |
0.0766 |
41.733 |
Sample 2 |
0.0693 |
36.866 |
Total Phenolic Content was calculated and expressed as Gallic acid equivalent (GAE)
TPC = (C×V)/m
Where,
TPC is in mg GAE/100g of the extract
C- Concentration of gallic acid from the calibration curve (mg/ml)
V- Volume of the extract solution (ml)
m- Mass of the extract (g)
Table 11
FORMULATION |
TPC (mg GAE/100g) |
F1 |
C×10/2 = 208.666 |
F2 |
C×10/2= 184.333 |
Based on the calibration curve, F1 exhibited a higher TPC value of 208.66 mg GAE/100g, while F2 showed 184.33 mg GAE/100g, indicating that F1 has greater antioxidant potential. As herbal formulations with TPC values above 100 mg GAE/100g are considered to exhibit strong antioxidant activity, both formulations fall within the acceptable range. This confirms the presence of phenolic compounds contributing to the oil’s therapeutic effectiveness in managing oxidative stress associated with diabetic neuropathy.
DISCUSSION
The formulated polyherbal oil was developed as a natural therapeutic alternative for managing diabetic neuropathy pain by incorporating bioactive herbal ingredients with known anti-inflammatory, analgesic, and antioxidant properties. The study involved the selection of medicinal plant-based ingredients based on traditional and scientific evidence supporting their nerve-protective and pain-relieving properties, as well as their potential to alleviate oxidative stress, inflammation, and nerve damage, which are the primary causes of diabetic neuropathy.
Pre-formulation studies were conducted to ensure the stability and compatibility of the selected ingredients which included preliminary phytochemical screening. The results confirmed the presence of key bioactive compounds such as alkaloids, flavonoids, phenols, tannins, and steroids, which contribute to the antioxidant and anti-inflammatory effects of formulation. Each test gave positive results which show the authenticity of all the herbs and confirms that they possess the necessary properties for developing an effective formulation.
Two formulations (F1 and F2) with varying compositions were prepared and subjected to physicochemical evaluations, including pH, viscosity, specific gravity, spreadability, washability, irritancy/sensitivity and stability analysis. The pH values of both formulations were within the acceptable range for topical application, ensuring skin compatibility. The viscosity and spreadability tests indicated that F1 exhibited better consistency and ease of application compared to F2, making it more suitable for transdermal absorption. The stability study conducted over three months revealed that both formulations maintained their physicochemical properties over time, with no phase separation or significant changes in color, odor, consistency, or pH, thereby confirming their shelf-life. The antioxidant potential was assessed using Total Phenolic Content (TPC) analysis, which demonstrated that the polyherbal oil had a higher TPC compared to individual plant extracts, indicating a synergistic effect of the combined ingredients. F1 exhibited a higher TPC value (208.66 mg GAE/g) compared to F2 (184.33 mg GAE/g), suggesting stronger antioxidant activity that may enhance its therapeutic potential in reducing oxidative stress linked to diabetic neuropathy. While both formulations shared a similar composition, the slight variations in ingredient proportions resulted in measurable differences in their evaluation test results. These differences suggest that while both formulations are effective and stable, F1 may offer superior therapeutic benefits due to its enhanced antioxidant activity and better spreadability. When compared to previous studies, this formulation offers an advantage by combining multiple bioactive ingredients for enhanced efficacy and targeted topical application. Though further in vitro and in vivo studies are needed to confirm the formulation’s mechanism of action, long-term stability, and clinical efficacy, its main purpose was to provide a natural, safe, and effective alternative, without the side effects commonly seen in pharmaceutical drugs for managing diabetic neuropathy pain through its anti-inflammatory, antioxidant, and neuroprotective properties.
CONCLUSION
The formulation and evaluation of sea buckthorn-enriched polyherbal oil demonstrated its potential therapeutic benefits in managing diabetic neuropathy pain. The bioactive compounds present in the formulation contributed to its antioxidant, anti-inflammatory, and neuroprotective properties, which may help alleviate oxidative stress and nerve damage. The formulation successfully met all required evaluation parameters, including stability and ensuring safety and effectiveness for topical application. Additionally, research on Sea Buckthorn Oil has demonstrated its high flavonoid and phenolic content, which supports neuroprotection and improved nerve function. Total Phenolic Content (TPC) analysis confirmed a higher phenolic concentration in F1, indicating greater antioxidant potential compared to F2. The findings suggest that this herbal oil formulation could serve as a promising natural remedy for diabetic neuropathy pain, offering an effective and safer alternative to conventional treatments.
REFERENCES
Rashmin Aklekar*, Rida Sayed, Sadiya Sabahat, Aamina Shaikh, Mantasha Sayyed, Rummanah Firdowsi, Exploring The Therapeutic Potential of Sea Buckthorn Enriched Polyherbal Oil Formulation for Alleviating Diabetic Neuropathy Pain, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 901-920. https://doi.org/10.5281/zenodo.15600592